Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

II Italian Study on Atrial Fibrillation (S.I.F.A. II): Prevention of Thromboembolic Events in Patients With Non Valvular Atrial Fibrillation.

NCT00244426 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00244426
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00244426 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
II Italian Study on Atrial Fibrillation (S.I.F.A. II): Prevention of Thromboembolic Events in Patients With Non Valvular Atrial Fibrillation.
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2000
Completion date
April 30, 2008
Enrollment
1,372 (actual)
Sites
132

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation